Alerts will be sent to your verified email
Verify EmailAARTIPHARM
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Aarti Pharmalabs Limited is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals, focusing on Active Pharmaceutical Ingredients and xanthine derivatives, leveraging process chemistry expertise and scale-up engineering.
Aarti Pharmalabs major competitors are Shilpa Medicare, Supriya Lifescience, AMI Organics, Aarti Drugs, Morepen Laboratories, Solara Active Pharma, IOL Chem & Pharma.
Market Cap of Aarti Pharmalabs is ₹6,679 Crs.
While the median market cap of its peers are ₹3,331 Crs.
Aarti Pharmalabs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | ||||||||||||||||||
Investor Presentation | Mar Jun Sep Dec | Mar Jun Sep Dec | ||||||||||||||||
Conference Call | Mar Jun Sep Dec | Jun Sep Dec | ||||||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|